Induction chemotherapy with MVP (mitomycin-C + vindesine + cisplatin) for stage III (T1-3, N2, M0) unresectable non-small cell lung cancer: the Toronto experience
- 31 March 1993
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 9 (1-6) , 377-382
- https://doi.org/10.1016/0169-5002(93)90694-s
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- The effects of preoperative chemotherapy on the resectability of non-small cell lung carcinoma with mediastinal lymph node metastases (N2 M0)The Annals of Thoracic Surgery, 1988
- The Role of Surgery in N2 Lung CancerSurgical Clinics of North America, 1987
- Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy report by the radiation therapy oncology groupCancer, 1987